Feb 26, 2026 05:21PM
Feb 26, 2026 04:01PM
Dec 30, 2025 08:00AM
Dec 30, 2025 08:00AM
Dec 4, 2025 07:10AM
Dec 4, 2025 07:02AM
Dec 4, 2025 07:00AM Denali Therapeutics and Royalty Pharma Announce $275 Million Royalty Funding Agreement
Nov 6, 2025 06:48PM
Nov 6, 2025 04:01PM
Nov 6, 2025 04:00PM
Nov 6, 2025 04:00PM
Oct 13, 2025 04:01PM
Oct 13, 2025 04:01PM
Aug 11, 2025 04:03PM Denali Therapeutics Inc. (DNLI) Misses Q2 EPS by 1c
Aug 11, 2025 04:01PM
Jul 7, 2025 08:03AM
Jul 7, 2025 08:00AM
May 6, 2025 05:38PM
May 6, 2025 04:01PM
Apr 2, 2025 08:04AM
Apr 2, 2025 08:00AM Denali Therapeutics Announces Initiation of BLA Filing for Accelerated Approval of Tividenofusp Alfa for the Treatment of Hunter Syndrome (MPS II) and Positive Ongoing Interactions with FDA on DNL126
Feb 27, 2025 05:02PM
Feb 27, 2025 04:01PM
Nov 6, 2024 04:01PM
Aug 1, 2024 08:51AM
Aug 1, 2024 06:45AM
May 7, 2024 06:35PM
May 7, 2024 04:01PM Denali Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights
Feb 27, 2024 09:30AM
Feb 27, 2024 08:05AM
Jan 8, 2024 08:00AM
Nov 7, 2023 05:23PM
Nov 7, 2023 04:01PM
Aug 8, 2023 05:18PM
Aug 8, 2023 04:01PM Denali Therapeutics Reports Second Quarter 2023 Financial Results and Business Highlights
May 8, 2023 04:49PM
May 8, 2023 04:01PM
Feb 27, 2023 04:39PM
Feb 27, 2023 04:01PM
Feb 27, 2023 04:01PM
Jan 9, 2023 08:00AM
Jan 9, 2023 08:00AM Denali Therapeutics Announces Key Anticipated 2023 Milestones for Its Therapeutic Portfolio for Neurodegeneration and Lysosomal Storage Diseases
Nov 3, 2022 04:01PM
Nov 3, 2022 04:01PM
Aug 8, 2022 04:01PM
Aug 8, 2022 04:01PM
May 5, 2022 04:01PM
May 5, 2022 04:01PM
Feb 28, 2022 04:01PM Denali Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Business Highlights
Feb 28, 2022 04:01PM

1,168,522 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All